Skip to main content
. 2019 Aug 29;11(9):e10061. doi: 10.15252/emmm.201810061

Figure 7. Slug inhibition reduces PH severity in our rat model of PF‐PH.

Figure 7

  • A
    Experimental schematic of the prevention protocol. All rats received bleomycin at day 0 and MCT at day 14. Starting at day 17, rats received five intratracheal nebulizations (twice a week for 3 weeks) of either a small interfering RNA (siRNA) directed against Slug (Si‐Slug) or scramble siRNA (Si‐Scrm).
  • B, C
    Relative expression of Slug protein (B) and mRNA (C) normalized to GAPDH.
  • D, E
    Right ventricular systolic pressure (RVSP) and (E) right ventricular hypertrophy index in PF‐PH rats treated with Si‐Slug compared to Si‐Scrm.
  • F–H
    Relative expression of fibronectin (F), collagen I (G), and collagen III (H) normalized to GAPDH.
  • I
    Masson's trichrome representative images and quantification of the Ashcroft score.
  • J
    Masson's trichrome representative images and quantification of vascular wall thickness.
  • K
    Masson's trichrome representative images and quantification of the vascular remodeling between non‐fibrotic and fibrotic areas of the lung.
  • L
    Representative images and quantification of Ki67‐positive (red) pulmonary vascular endothelial cells (EC, vWF in green) and smooth muscle cells (SMC, aSMA in white).
Data information: Values are expressed as mean ± SEM. The number of samples per group for each experiment is included within each bar graph. Statistical test: panels (B–J): t‐test; panels (K and L): ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).